Head-to-head trials comparing centanafadine, an investigational therapy for adults with attention-deficit/hyperactivity disorder (ADHD), with other treatment options are lacking.
No takes yet. Share an insight, caveat, or question.
Schein et al. (2024) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: